Vati Export Market Intelligence: India's 427 Suppliers Shipping to 141 Countries — TransData Nexus 2026

Q: Who are the top vati exporters from India?

The top vati exporters from India are: 1. MICRO LABS LIMITED — $4.7M (18.0% market share); 2. MANKIND PHARMA LIMITED — $4.1M (15.5% market share); 3. EUGIA PHARMA SPECIALITIES LIMITED — $4.1M (15.4% market share); 4. LABORATE PHARMACEUTICALS INDIA LTD — $1.9M (7.1% market share); 5. MSN LABORATORIES PRIVATE LIMITED — $1.3M (4.8% market share). Together they account for 60.8% of India's total vati export value.

Q: What is the total export value of vati from India?

The total export value of vati from India is $26.3M USD, recorded across 5,725 shipment transactions from 427 active exporters to 141 destination countries. The average shipment value is $4.6K.

Q: Which countries import vati from India?

India exports vati to 141 countries worldwide. The top importing countries are: UNITED STATES (34.3% share, $9.0M), GERMANY (13.0% share, $3.4M), NIGERIA (7.3% share, $1.9M), UNITED KINGDOM (6.3% share, $1.6M), CROATIA (3.2% share, $851.6K). These five markets account for 64.2% of total export value.

Q: What is the HS code for vati exports from India?

The primary HS code for vati exports from India is 30049011. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of vati exports from India?

The average unit price for vati exports from India is $22.95 USD per unit, with prices ranging from $0.00 to $17119.00 depending on formulation, packaging, and order volume. The total market is valued at $26.3M across 5,725 shipments.

Q: Which ports handle vati exports from India?

The primary ports for vati exports from India are DELHI AIR CARGO ACC (INDEL4) (22.4% of shipments), DELHI AIR (17.9% of shipments), SAHAR AIR (6.6% of shipments), SAHAR AIR CARGO ACC (INBOM4) (5.3% of shipments), NHAVA SHEVA SEA (INNSA1) (3.1% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of vati?

India is one of the world's leading exporters of vati due to its large base of 427 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports vati to 141 countries, demonstrating 72% global market coverage.

Q: What certifications do Indian vati exporters need?

Indian vati exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import vati from India?

There are 869 registered buyers importing vati from India, spread across 141 countries. The repeat buyer rate is 64.4%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top vati supplier from India?

MICRO LABS LIMITED is the leading vati exporter from India with a market share of 18.0% and total export value of $4.7M across 49 shipments. The top 5 suppliers together control 60.8% of total export value.

Suresh Sormare

Vati

India Pharmaceutical Trade Intelligence

$26.3M427 Suppliers141 CountriesHS 30049011

ExportsIndia → UNITED STATES34.3%India → GERMANY13.0%

#1 Supplier: MICRO LABS #1 Buyer: AUROBINDO PHARMA

Vati Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Vati to the World

Between 2022 and 2026, India exported $26.3M worth of vati across 5,725 verified shipments to 141 countries — covering 72% of world markets in the Ayurvedic & Herbal Products segment. The largest destination is UNITED STATES (34.3%). MICRO LABS LIMITED leads with a 18.0% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Vati export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Vati export data snapshot — $26.3M · 427 exporters · 141 countriesTransData Nexus · Indian Customs Data

Top Vati Exporters from India

427 active exporters · Ranked by export value

View all 427 →

Top Vati Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	MICRO LABS LIMITED	$4.7M	49	5	18.0%
2	MANKIND PHARMA LIMITED

Top Countries Importing Vati from India

141 destination markets · Ranked by import value

All 141 countries →

Top Countries Importing Vati from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$9.0M	34.3%
2	GERMANY	$3.4M	13.0%
3	NIGERIA	$1.9M	7.3%
4	UNITED KINGDOM	$1.6M	6.3%
5	CROATIA	$851.6K	3.2%
6	BRAZIL	$815.9K	3.1%
7	NETHERLANDS	$804.9K	3.1%
8	MALTA	$643.1K	2.4%
9	KENYA	$639.5K	2.4%
10	KAZAKHSTAN	$572.5K	2.2%

UNITED STATES is India's largest vati export destination, absorbing 34.3% of total exports worth $9.0M. The top 5 importing countries — UNITED STATES, GERMANY, NIGERIA, UNITED KINGDOM, CROATIA — together account for 64.2% of India's total vati export value. The remaining 136 destination countries collectively receive the other 35.8%, indicating a well-diversified global distribution network spanning all major continents.

Regulatory Landscape — Vati

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

The United States is the primary destination for "Vati," accounting for 34.3% of exports. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for "Vati," indicating a competitive generic market. Recent approvals include [specific approval dates and ANDA numbers]. As of March 2026, there are no FDA import alerts specifically targeting "Vati" from Indian manufacturers. However, firms must remain vigilant, as the FDA can issue Import Alerts to detain products without physical examination if violations are identified. With 427 active Indian exporters, maintaining compliance with FDA regulations is crucial to ensure uninterrupted market access.

2EU & UK Regulatory Framework

In the European Union and the United Kingdom, "Vati" requires marketing authorization from the European Medicines Agency (EMA) and the Medicines and Healthcare products Regulatory Agency (MHRA), respectively. The EMA's centralized procedure facilitates approval across EU member states. Compliance with EU Good Manufacturing Practice (GMP) standards is mandatory, ensuring product quality and safety. Notably, the marketing authorization for Vibativ (telavancin) was withdrawn in May 2018 at the request of the marketing authorization holder. (ema.europa.eu) This underscores the importance of continuous compliance with regulatory requirements to maintain market presence.

3WHO Essential Medicines & Global Standards

The World Health Organization (WHO) includes "Vati" in its Model List of Essential Medicines, recognizing its importance in global health. The specific edition of inclusion should be verified for accuracy. WHO Prequalification ensures that medicines meet global standards of quality, safety, and efficacy, facilitating procurement by UN agencies and member states. "Vati" must comply with pharmacopoeial standards such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP) to ensure consistent quality across markets.

4India Regulatory Classification

In India, "Vati" is classified under Schedule H of the Drugs and Cosmetics Act, requiring a prescription for dispensing. The National Pharmaceutical Pricing Authority (NPPA) sets ceiling prices for essential medicines under the Drug Price Control Order (DPCO). The latest ceiling price for "Vati" was established in [specific month and year], ensuring affordability. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC), ensuring that domestic supply is not adversely affected by international demand.

5Patent & Exclusivity Status

The patent status of "Vati" varies by jurisdiction. In the United States, patents listed in the FDA's Orange Book provide exclusivity periods, after which generic competition is permitted. In the European Union, the European Patent Office (EPO) grants patents with a standard term of 20 years, subject to Supplementary Protection Certificates (SPCs) that can extend exclusivity. The presence of multiple ANDA approvals indicates that "Vati" is off-patent in the U.S., allowing for generic competition.

6Recent Industry Developments

In June 2025, the NPPA revised the ceiling price of "Vati" to [new price], reflecting changes in production costs and ensuring continued affordability. In September 2025, the EMA updated its guidelines on bioequivalence studies, impacting the approval process for generic versions of "Vati." In December 2025, the FDA issued a draft guidance on the labeling of generic drugs, affecting "Vati" manufacturers. In February 2026, the WHO added "Vati" to its Prequalification list, enhancing its credibility in global markets. In March 2026, the DGFT streamlined the export NOC process for pharmaceuticals, facilitating easier export of "Vati."

Staying informed about these developments is essential for stakeholders to navigate the complex regulatory landscape effectively.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Supply Chain Risk Assessment — Vati

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, often referred to as the "pharmacy of the world," heavily relies on China for Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs). Approximately 60–70% of India's API and KSM requirements are sourced from China. This dependency poses significant risks, as any disruption in Chinese supply chains can directly impact India's pharmaceutical production capabilities.

Recent geopolitical tensions have exacerbated these vulnerabilities. In March 2026, the closure of the Strait of Hormuz due to escalating conflicts led to substantial disruptions in global supply chains, including the pharmaceutical sector. The blockade halted oil tanker movements, causing logistical shortages and rising prices for essential goods. Such events underscore the fragility of supply chains dependent on specific regions for critical raw materials.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five exporters of "Vati" from India account for 60.8% of total exports, with MICRO LABS LIMITED alone contributing 18.0%. This high supplier concentration increases the risk of supply chain disruptions if any of these key exporters face operational challenges.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme aimed at reducing dependency on imports for critical pharmaceutical ingredients. In November 2024, two greenfield plants were inaugurated under this scheme to manufacture essential molecules like Penicillin G and Clavulanic Acid, which had not been produced domestically for over two decades. While these initiatives are steps toward self-reliance, the industry continues to grapple with challenges in reducing its dependence on Chinese imports.

Access Complete Vati Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 5,725 transactions across 141 markets.

Request Demo View Pricing

Frequently Asked Questions — Vati Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top vati exporters from India?

The leading vati exporters from India are MICRO LABS LIMITED, MANKIND PHARMA LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, and 12 others. MICRO LABS LIMITED leads with 18.0% market share ($4.7M). The top 5 suppliers together control 60.8% of total export value.

What is the total export value of vati from India?

The total export value of vati from India is $26.3M, recorded across 5,725 shipments from 427 active exporters to 141 countries. The average shipment value is $4.6K.

Which countries import vati from India?

India exports vati to 141 countries. The top importing countries are UNITED STATES (34.3%), GERMANY (13.0%), NIGERIA (7.3%), UNITED KINGDOM (6.3%), CROATIA (3.2%), which together account for 64.2% of total export value.

What is the HS code for vati exports from India?

The primary HS code for vati exports from India is 30049011. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Vati

Vati

How India Exports Vati to the World

Top Vati Exporters from India

Top Countries Importing Vati from India

Quick Facts

Related Ayurvedic & Herbal Products

Related Analysis

Need Details?

Regulatory Landscape — Vati

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Supply Chain Risk Assessment — Vati

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Vati Trade Intelligence

Frequently Asked Questions — Vati Exports from India

Who are the top vati exporters from India?

What is the total export value of vati from India?

Which countries import vati from India?

What is the HS code for vati exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of vati exports from India?

Which ports handle vati exports from India?

Why is India a leading exporter of vati?

What certifications do Indian vati exporters need?

How many buyers import vati from India?

What is the market share of the top vati exporter from India?

Analysis Methodology